Copper Metabolism-Related Genes as Biomarkers in Colon Adenoma and Cancer

铜代谢相关基因作为结肠腺瘤和癌症的生物标志物

阅读:11
作者:Taikun Zhang ,Ying Fu

Abstract

Purpose: To elucidate the role of copper (Cu) metabolism in the progression of colon adenoma (CA) to colorectal cancer (CRC) and to identify potential biomarkers and therapeutic targets through comprehensive bioinformatics analysis. Patients and methods: Datasets associated with colon adenoma were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) between CA samples and normal controls (NC) were intersected with genes related to copper metabolism (CMRGs) and DEGs between CRC and CA. Five machine-learning algorithms were employed to identify biomarkers. The degree of immune infiltration was evaluated using single-sample Gene Set Enrichment Analysis (ssGSEA), and the expression profiles of these biomarkers across various cell types were further characterized using single-cell RNA sequencing (scRNA-seq). The expression levels of the identified genes were validated using quantitative polymerase chain reaction (qPCR) and data from the Human Protein Atlas (HPA) database. Results: Five biomarkers were identified: ZEB1, ABCA1, SLC24A3, CAV1, and FLNA. Functional enrichment analysis revealed significant pathway alterations in the low-expression groups of CAV1 (eg, phagosome pathway) and FLNA (eg, ribosome pathway). Significant differences in the infiltration abundance of macrophages and mast cells were observed between CA and NC. scRNA-seq analysis demonstrated that these biomarkers were expressed in fibroblasts, lymphocytes, goblet cells, B cells, and macrophages. The consistency of gene expression between patient samples and public datasets was confirmed through qPCR and HPA data. Conclusion: This study explores the role of copper metabolism in colon adenoma progression using bioinformatics. Five genes (ZEB1,ABCA1, SLC24A3, CAV1, FLNA) were identified as potential biomarkers. These genes correlate with immune infiltration and may serve as diagnostic and therapeutic targets. Further clinical validation is needed. Keywords: biomarkers; colon adenoma; copper metabolism; machine learning; single-cell RNA sequencing.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。